BR

Bommoju Rashmitha

Active Director Director DIN 11254089
DIN 11254089 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bommoju Rashmitha

Data last updated:

Bommoju Rashmitha is a Director at Glyzor Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11254089
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20252025Active

Board colleagues of Bommoju Rashmitha

NameDINCompanyDesignation
Rajesh Tadakamalla11254088Glyzor Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Glyzor Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bommoju Rashmitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bommoju Rashmitha

Bommoju Rashmitha currently holds 1 directorship: Glyzor Pharmaceuticals Private Limited (Director, since 22 Aug 2025).

Bommoju Rashmitha was first appointed on 22 Aug 2025 as Director at Glyzor Pharmaceuticals Private Limited.

The current boards of Bommoju Rashmitha's companies include Rajesh Tadakamalla (Glyzor Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available